|
WO2021031148A1
|
|
Crystal form of gonadotropin releasing hormone antagonist, preparation method therefor, and use thereof
|
|
WO2021031102A1
|
|
Crystal form of daprodustat, preparation method therefor and use thereof
|
|
WO2021016929A1
|
|
Cocrystal form a of elagolix and pyrimethamine, preparation method therefor and use thereof
|
|
WO2020198939A1
|
|
Crystalline form a of 2,2-bis(4-fluorophenyl)-2-phenylacetamide and preparation method therefor and application thereof
|
|
CN112020489A
|
|
Crystal form A of 2- (2, 5-dioxopyrrolidine-1-yl) ethyl methyl fumarate and preparation method and application thereof
|
|
WO2020181555A1
|
|
Crystal form a of nhe3 inhibitor, preparation method therefor and application thereof
|
|
WO2020155057A1
|
|
γ-AMINOBUTYRIC ACID MODULATOR CRYSTAL FORM X, PREPARATION METHOD AND APPLICATION THEREOF
|
|
CN110869351A
|
|
Crystalline forms of (R) -N- (4-chlorophenyl) -2- (cis-4- (6-fluoroquinolin-4-yl) cyclohexyl) propionamide
|
